Literature DB >> 17143778

Further evidence that the chromogranin B gene confers predisposition to schizophrenia: a family-based association study in Chinese.

S Wu1, J Ma, Q Xing, Y Xu, J Meng, D Cao, G Feng, L He.   

Abstract

The Chromogranin B (CHGB) gene has been proposed as a candidate gene for predisposition to schizophrenia due to its location on the genome, the evidence of genetic studies, and its functional role in schizophrenia. To investigate its association with schizophrenia using case-control analysis, we genotyped eight single nucleotide polymorphisms (SNPs) and performed transmission disequilibrium tests (TDT) using 192 Han Chinese trios. The G allele of IVS4 + 808A > G showed a trend of over-transmission from heterozygous parents to affected offspring (P = 0.06), although no significant over-transmission was found for individual markers. Furthermore, a significant transmission was observed for the common haplotype G-G-A-G-C (P = 0.0018). Overall, our results suggest that at least one locus in or close to the CHGB gene confers risk of the disorder and strengthen the evidence that CHGB is a promising susceptibility gene for schizophrenia in Chinese population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143778     DOI: 10.1007/s00702-006-0600-9

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  13 in total

1.  Meta-analysis of linkage studies.

Authors:  J A Badner; L R Goldin
Journal:  Genet Epidemiol       Date:  1999       Impact factor: 2.135

2.  PE-11, a peptide derived from chromogranin B, in the human brain.

Authors:  J Marksteiner; R Bauer; W A Kaufmann; E Weiss; U Barnas; H Maier
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

3.  Pedigree disequilibrium tests for multilocus haplotypes.

Authors:  Frank Dudbridge
Journal:  Genet Epidemiol       Date:  2003-09       Impact factor: 2.135

4.  Failure to find association between TRAR4 and schizophrenia in the Chinese Han population.

Authors:  S Duan; J Du; Y Xu; Q Xing; H Wang; S Wu; Q Chen; X Li; X Li; J Shen; G Feng; L He
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

5.  A contribution to genome-wide association studies: search for susceptibility loci for schizophrenia using DNA microsatellite markers on chromosomes 19, 20, 21 and 22.

Authors:  Y Kitao; T Inada; T Arinami; C Hirotsu; S Aoki; Y Iijima; T Yamauchi; G Yagi
Journal:  Psychiatr Genet       Date:  2000-09       Impact factor: 2.458

6.  Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia.

Authors:  M Landén; B Grenfeldt; P Davidsson; M Stridsberg; B Regland; C G Gottfries; K Blennow
Journal:  Eur Neuropsychopharmacol       Date:  1999-06       Impact factor: 4.600

7.  Polymorphisms of chromogranin B gene associated with schizophrenia in Chinese Han population.

Authors:  Bifeng Zhang; Zheng Tan; Changshun Zhang; Yongyong Shi; Zhixin Lin; Niufan Gu; Guoyin Feng; Lin He
Journal:  Neurosci Lett       Date:  2002-05-03       Impact factor: 3.046

8.  Association between chromogranin b gene polymorphisms and schizophrenia in the Japanese population.

Authors:  Yoshimi Iijima; Toshiya Inada; Tsuyuka Ohtsuki; Hisashi Senoo; Masaki Nakatani; Tadao Arinami
Journal:  Biol Psychiatry       Date:  2004-07-01       Impact factor: 13.382

9.  Association analysis of polymorphisms in the upstream region of the human dopamine D4 receptor gene in schizophrenia.

Authors:  Qing-he Xing; Sheng-nan Wu; Zhi-guang Lin; Hua-fang Li; Jian-dong Yang; Guo-yin Feng; Ming-tai Wang; Wei-wei Yang; Lin He
Journal:  Schizophr Res       Date:  2003-12-01       Impact factor: 4.939

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  3 in total

1.  Decreased cerebrospinal fluid secretogranin II concentrations in severe forms of bipolar disorder.

Authors:  Joel Jakobsson; Mats Stridsberg; Henrik Zetterberg; Kaj Blennow; Carl-Johan Ekman; Anette G M Johansson; Carl Sellgren; Mikael Landén
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

Review 2.  Chromogranin peptides in brain diseases.

Authors:  Michael Willis; Irmgard Leitner; Kurt A Jellinger; Josef Marksteiner
Journal:  J Neural Transm (Vienna)       Date:  2011-04-30       Impact factor: 3.575

3.  Gender-Specific Associations between CHGB Genetic Variants and Schizophrenia in a Korean Population.

Authors:  Joong Gon Shin; Jeong Hyun Kim; Chul Soo Park; Bong Jo Kim; Jae Won Kim; Ihn Geun Choi; Jaeuk Hwang; Hyoung Doo Shin; Sung Il Woo
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.